Pain assessment in cognitive impairment.

Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med (2012) 5.64

Statins for the prevention of dementia. Cochrane Database Syst Rev (2009) 2.38

A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease. Int J Geriatr Psychiatry (2004) 2.21

Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev (2009) 1.56

Statins for the prevention of dementia. Cochrane Database Syst Rev (2016) 1.43

Can we afford not to have integrated dementia services? Age Ageing (2007) 1.38

Determining the minimum clinically important differences for outcomes in the DOMINO trial. Int J Geriatr Psychiatry (2010) 1.26

Statins for the treatment of dementia. Cochrane Database Syst Rev (2010) 1.23

Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease. PLoS One (2010) 1.07

Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study. Mol Neurodegener (2011) 1.01

The importance of validating the diagnosis of coronary heart disease when measuring secondary prevention: a cross-sectional study in general practice. Pharmacoepidemiol Drug Saf (2002) 0.93

Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS). Neurobiol Aging (2012) 0.92

Statins for the treatment of dementia. Cochrane Database Syst Rev (2014) 0.92

A multi-center study of ACE and the risk of late-onset Alzheimer's disease. J Alzheimers Dis (2011) 0.89

Vascular dementia: prevention and treatment. Clin Interv Aging (2006) 0.87

AD2000: design and conclusions. Lancet (2004) 0.87

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. Trials (2009) 0.86

Cochrane review on 'Statins for the treatment of dementia'. Int J Geriatr Psychiatry (2012) 0.86

TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease. Neurobiol Aging (2007) 0.84

Can statins prevent or help treat Alzheimer's disease? J Alzheimers Dis (2010) 0.83

A single nucleotide polymorphism in CHAT influences response to acetylcholinesterase inhibitors in Alzheimer's disease. Pharmacogenet Genomics (2006) 0.83

Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids. Trials (2013) 0.81

Assessment of factors that influence physician decision making regarding medication use in patients with dementia at the end of life. Int J Geriatr Psychiatry (2013) 0.79

Development and application of medication appropriateness indicators for persons with advanced dementia: a feasibility study. Drugs Aging (2015) 0.77

Analysis of the 5HT-2A T102C receptor polymorphism and psychotic symptoms in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2007) 0.76

Development of a cell phone-based video streaming system for persons with early stage Alzheimer's disease. Conf Proc IEEE Eng Med Biol Soc (2008) 0.75

Next generation sequencing of CLU, PICALM and CR1: pitfalls and potential solutions. Int J Mol Epidemiol Genet (2012) 0.75

Managing osteoarthritis pain in the older population. J Pain Palliat Care Pharmacother (2013) 0.75

Introduction to genetic epidemiology. Optometry (2010) 0.75

Visualization and Post-processing of 5D Brain Images. Conf Proc IEEE Eng Med Biol Soc (2005) 0.75